New York - Session 2025-2026
Title: Relates to the labeling of mifepristone, misoprostol, and their generic alternatives
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
| Date | Event | Detail |
|---|---|---|
| 2025-01-15 | Introduced | Bill introduced |
| 2025-01-22 | Status | in_committee |
| 2025-01-22 | Latest Action | Assembly Floor Calendar |